Physician profile
Maria L Phillips
NPI 1669007282
$7,318.59
in general payments reported to CMS, 2019-2025
37 companies · $1,689 in 2025
The $1,689 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,157 · 2022: $1,250 · 2023: $1,515 · 2024: $1,707 · 2025: $1,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,911.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,827.63 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,740.05 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $586.06 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $478.59 | 2021-2025 | |
| Lilly USA, LLC | $437.51 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $233.31 | 2021-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $179.55 | 2021-2024 | Rexulti |
| Boston Scientific Corporation | $144.35 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Exact Sciences Corporation | $128.00 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $114.55 | 2022-2024 | Repatha, Otezla, Prolia |
| Astellas Pharma US INC | $107.89 | 2022-2024 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.31 | 2023-2025 | Jardiance |
| Upsher-Smith Laboratories LLC | $99.58 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $97.48 | 2022-2025 | Contrave |
| Biohaven Pharmaceutical Holding Company LTD. | $92.42 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $87.04 | 2024-2025 | Rexulti |
| Medtronic, INC. | $74.14 | 2025 | Synchromedii, Kyphon Express II Kyphopak Tray |
| Glaxosmithkline, LLC. | $66.55 | 2021-2025 | Arexvy, Shingrix |
| Biohaven Pharmaceuticals, INC. | $66.31 | 2021 | |
| Eisai INC. | $62.70 | 2021 | |
| Sanofi-Aventis U.S. LLC | $58.12 | 2021-2022 | |
| Dexcom, INC. | $57.85 | 2021-2024 | Dexcom G6 Transmitter |
| Dynavax Technologies Corporation | $47.58 | 2023-2024 | Heplisav-B |
| Corcept Therapeutics | $45.06 | 2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $44.45 | 2024 | Voquezna |
| Amarin Pharma, INC. | $42.39 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $41.67 | 2023-2025 | Ajovy |
| Abbott Laboratories | $38.45 | 2023-2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $38.36 | 2022-2024 | Spravato |
| Idorsia Pharmaceuticals US INC | $28.73 | 2022-2024 | Quviviq |
| Axsome Therapeutics, INC. | $27.35 | 2024-2025 | Auvelity |
| Mylan Specialty L.P. | $27.24 | 2024 | Yupelri |
| Antares Pharma, INC. | $27.10 | 2024 | Xyosted |
| Genentech USA, INC. | $19.95 | 2021 | |
| Merck Sharp & Dohme LLC | $17.21 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.71 | 2023 | Eliquis |
| Sunovion Pharmaceuticals INC. | $10.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.